Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea flag South Korea · Delayed Price · Currency is KRW
27,350
-50 (-0.18%)
Apr 29, 2026, 3:30 PM KST

Ildong Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
27,664-4,576-78,928-141,585-99,705
Upgrade
Depreciation & Amortization
22,57625,93528,31929,54529,311
Upgrade
Loss (Gain) From Sale of Assets
2,1464,908-1,133282.22101.53
Upgrade
Asset Writedown & Restructuring Costs
2,5369,8573,49219,004550.27
Upgrade
Loss (Gain) From Sale of Investments
-7,643-1,955-439.72-2,325862.82
Upgrade
Loss (Gain) on Equity Investments
-283.69273.490.360.541.67
Upgrade
Stock-Based Compensation
215.08129.79-5.7318.0916.55
Upgrade
Provision & Write-off of Bad Debts
243.8303.04-574.49-85.1-1,142
Upgrade
Other Operating Activities
-1,0371,44924,14056,02060,178
Upgrade
Change in Accounts Receivable
-2,6543,634-2,089-1,407-1,857
Upgrade
Change in Inventory
-13,506-2,50813,852-15,5326,617
Upgrade
Change in Accounts Payable
229.27-2,9734,2357,9362,339
Upgrade
Change in Other Net Operating Assets
-11,537-6,185-27,484-5,412-8,639
Upgrade
Operating Cash Flow
18,95128,293-36,615-53,541-11,366
Upgrade
Operating Cash Flow Growth
-33.02%----
Upgrade
Capital Expenditures
-13,647-10,679-13,201-11,873-14,626
Upgrade
Sale of Property, Plant & Equipment
161.7129,336307.0167.538.14
Upgrade
Divestitures
184.3279.74--4,142
Upgrade
Sale (Purchase) of Intangibles
-3,637-1,150-1,968-6,401-4,876
Upgrade
Investment in Securities
6,64912,759-1,601-7,401-26,180
Upgrade
Other Investing Activities
-913.62-344.221,025-842.621,133
Upgrade
Investing Cash Flow
-2,27918,458-20,360-26,435-43,368
Upgrade
Short-Term Debt Issued
14,71515,03084,50023,000141,600
Upgrade
Long-Term Debt Issued
-50,00029,25017,00099,400
Upgrade
Total Debt Issued
14,71565,030113,75040,000241,000
Upgrade
Short-Term Debt Repaid
-21,920-87,519-48,700-20,000-133,600
Upgrade
Long-Term Debt Repaid
-26,369-3,573-4,850-23,118-10,723
Upgrade
Total Debt Repaid
-48,289-91,092-53,550-43,118-144,323
Upgrade
Net Debt Issued (Repaid)
-33,575-26,06260,200-3,11896,677
Upgrade
Issuance of Common Stock
--124.83-1,745
Upgrade
Repurchase of Common Stock
-0.87-0.17-1,942--
Upgrade
Dividends Paid
-60.16-76.8-160-120-
Upgrade
Other Financing Activities
9,547-366.08-70.4-49.31-0
Upgrade
Financing Cash Flow
-24,088-27,85458,152-3,287104,316
Upgrade
Foreign Exchange Rate Adjustments
-4.84112.18-64.19-177.2440.44
Upgrade
Net Cash Flow
-7,42219,0091,112-83,44050,022
Upgrade
Free Cash Flow
5,30417,614-49,817-65,413-25,992
Upgrade
Free Cash Flow Growth
-69.89%----
Upgrade
Free Cash Flow Margin
0.94%2.86%-8.29%-10.26%-4.64%
Upgrade
Free Cash Flow Per Share
172.61630.60-1843.01-2483.08-1092.76
Upgrade
Cash Interest Paid
7,99513,53410,4125,6434,041
Upgrade
Cash Income Tax Paid
1,902560.83724.882,524-290.57
Upgrade
Levered Free Cash Flow
-20,183-6,7075,487-159,418101,154
Upgrade
Unlevered Free Cash Flow
-12,5743,25414,690-153,300107,752
Upgrade
Change in Working Capital
-27,467-8,032-11,485-14,416-1,540
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.